简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Exicure获得纳斯达克听证会小组的延期

2024-09-19 04:25

  • Exicure (NASDAQ:XCUR) said on Wednesday that Nasdaq Hearings Panel has granted an extension to continue the company’s listing subject to the company evidencing compliance with all applicable criteria by November 14, 2024.
  • The company has regained compliance with Nasdaq’s minimum bid price requirement and exchanged approximately $1M of indebtedness for equity at a conversion price of $3 per share.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。